Skip to main content
  • Home
  • Articles
    • Archive from 2022 July
    • Archive 1960 to 2022 June
    • Accepted Articles
    • Published Ahead-of-Print
    • Supplement
  • About
  • For Authors
  • Podcasts

Doctor, my dentist wants your opinion

< Back to Listing

Share this Article

Singapore Med J 2013; 54:11-14; http://dx.doi.org/10.11622/smedj.2013004
Doctor, my dentist wants your opinion

  • Abstract
  • PDF
  • References

Chee FY, How CH
Correspondence:  Dr Chee Fang Yee, chee.fang.yee@nhcs.com.sg

ABSTRACT
Dental surgery is very common, and it is important for our dental colleagues to understand the medical history and chronic medications of our co-managed patients. Antibiotic prophylaxis is currently recommended only for patients at high risk for infective endocarditis when undergoing high-risk dental procedures. Good dental hygiene can prevent more infective endocarditis than prophylactic antibiotic therapy, as transient bacteraemia is common in daily activities such as the brushing and flossing of teeth.
Most dental surgeries can generally be performed on patients taking a daily dose of aspirin, but the dentist must be able to assess the risk-benefit ratio of employing local measures of haemostasis versus stopping the antiplatelet therapy. Patients on antiplatelet with recent coronary artery stenting should be referred to their primary cardiologist regarding the cessation of these agents before any surgery.

 
Keywords: antibiotic prophylaxis, antiplatelet therapy, dental surgery, infective endocarditis
Singapore Med J 2013; 54:11-14; http://dx.doi.org/10.11622/smedj.2013004
http://smj.org.sg/sites/default/files/5401/5401practice1.pdf

REFERENCES

1. Burnette-Curley D, Wells V, Viscount H, et al. FimA, a major virulence factor associated with Streptococcus parasanguis endocarditis. Infect Immun 1995; 63:4669-74.
PMid:7591121
 
2. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 116:1736-54. 
http://dx.doi.org/10.1161/CIRCULATIONAHA.106.183095
 
3. Pallasch TJ. Antibiotic prophylaxis: problems in paradise. Dent Clin North Am 2003; 47:665-79. 
http://dx.doi.org/10.1016/S0011-8532(03)00037-5
 
4. Durack DT. Prevention of infective endocarditis. N Engl J Med 1995; 332:38-44.
http://dx.doi.org/10.1056/NEJM199501053320107
 
5. Nishimura RA, Carabello BA, Faxon DP, et al. ACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118:887-96.
http://dx.doi.org/10.1161/CIRCULATIONAHA.108.190377
 
6. The Cardiac Society of Australia and New Zealand. Guidelines for the use of antiplatelet therapy in patients with coronary stents undergoing non-cardiac surgery [online]. Available at: www.csanz.edu.au/Portals/0/Guidelines/Practice/Use%20of%20antiplatelet%2.... Accessed December 20, 2012.
×

Around the Site

Home

About SMJ

For Reviewers

Sign Up for Alerts

Issues

Current Issue

All Issues

Online First

Supplement

CME

For Authors

Instructions for Authors

Submit Manuscript


Follow us on:
        

More Links

Contact Us

Copyright

Advertise

SMJ Forms

Privacy Policy

SMA Home

Copyright 2021. Singapore Medical Association. All Rights Reserved.